GLP-3R Peptide | Triple Agonist 20mg (GLP-1, GIP & Glucagon Receptor Research)

Understanding GLP-3R Peptide

GLP-3R Peptide 20mg is a next-generation research peptide currently under active scientific investigation. Scientists describe it as a triple agonist because it interacts with three key metabolic receptors — GLP-1, GIP, and glucagon — each playing a crucial role in energy balance and nutrient regulation.

In laboratory environments, studies with GLP-3R have provided valuable insights into how multi-receptor activation influences glucose utilization, lipid regulation, and metabolic adaptation. Its unique triple-pathway mechanism distinguishes it from single or dual receptor analogues, allowing researchers to explore a broader range of metabolic and endocrinological interactions.

Because of its advanced structure and receptor profile, GLP-3R remains a focus in metabolic, cardiovascular, and hormonal signaling research, offering scientists a versatile tool for controlled laboratory study.

Research Applications

GLP-3R 20mg is used in controlled research to explore biological processes involving metabolic regulation, energy expenditure, and hormonal communication. Ongoing studies investigate how triple-agonist peptides like GLP-3R may help clarify the complex relationships between glucose homeostasis, appetite signaling, and cardiovascular biomarkers.

Researchers also study its effects on insulin sensitivity, lipid metabolism, and gene expression associated with metabolic balance and adaptive energy pathways.

Product Care

Store in a cool, dry place away from light. Once reconstituted, refrigerate immediately. For long-term preservation, freeze at –20 °C to maintain stability and integrity.

Product Note

All Everwell Peptides products are provided in lyophilized (powder) form for maximum stability and must be reconstituted before laboratory use. Products are intended strictly for in-vitro research purposes only. They are not approved for human or veterinary use, and no dosing information is provided.